Evidence map›Paper›PMID 23107233›Full record

ArticleRespiratory care2013

Pulmonary mucormycosis: what is the best strategy for therapy?

Juan F Fernandez, Diego J Maselli, Tamara Simpson, Marcos I Restrepo

Abstract read
In one paragraph

Article in Respiratory care, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. The Black Fungus: A Rare Case of Pulmonary Mucormycosis.HCA healthcare journal of medicine · 2025
    Article
  4. Article
  5. Article
  6. Review
  7. Access microbiology · 2023
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Mucormycosis causing pulmonary artery aneurysm.Respiratory medicine case reports · 2015
    Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Juan F FernandezDivision of Pulmonary Diseases and Critical Care, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229, USA. Jfelipefernandez@hotmail.com
Diego J Maselli
Tamara Simpson
Marcos I Restrepo

Funding

Effect of macrolides as immunomodulators in patients with sepsis and pneumoniaK23HL096054 · NHLBI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI RESTREPO, MARCOS I. · 2010 to 2014
$689k
NHLBI NIH HHS K23 HL096054NHLBI NIH HHS K23HL096054
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Acute Kidney InjuryAdultAmphotericin BAntifungal AgentsDebridementEchinocandinsHumansLipopeptidesLung Diseases, FungalMaleMicafunginMucormycosisPneumonectomyTriazolesAmphotericin BAntifungal AgentsEchinocandinsLipopeptidesMicafunginposaconazoleTriazoles

Identifiers

PMID23107233
PMCPMC4066629

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.